REQUEST A DEMO
Total
USD $0.00
Search more companies

Zeti Pharmaceuticals Pharmazeti Cia.Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Zeti Pharmaceuticals Pharmazeti Cia.Ltda Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Zeti Pharmaceuticals Pharmazeti Cia.Ltda is a company based in Ecuador, with its head office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on February 01, 2019. 10 (2023) employees currently work for Zeti Pharmaceuticals Pharmazeti Cia.Ltda. In 2023, the company reported a net sales revenue drop of 58.17%. Its’ total assets recorded a negative growth of 22.31%.

Headquarters
Av Dr Rodrigo Chavez 0270, Corporativo Iii Bldg. , Floor 305
Guayaquil; Guayas;

Contact Details: Purchase the Zeti Pharmaceuticals Pharmazeti Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Zeti Pharmaceuticals Pharmazeti Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Zeti Pharmaceuticals Pharmazeti Cia.Ltda report to view the information.
Registered Capital:
Purchase the Zeti Pharmaceuticals Pharmazeti Cia.Ltda report to view the information.
Incorporation Date:
February 01, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Davtocom S.A.
100%
Company Performance
Financial values in the chart are available after Zeti Pharmaceuticals Pharmazeti Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-58.17%
Total operating revenue
-57.83%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-22.31%
Total equity
3.26%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-62.11%
Quick Ratio
-0.49%
Cash Ratio
-0.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?